Loading
MABALL

About MABALL

Maball contains Rituximab as composition. Rituximab is a genetically engineered chimeric human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light and heavy-chain variable region sequences and human constant region sequences. Maball belongs to Anti Neoplastic therapy of Oncology Division and it is available in 2 forms: Maball 100Mg Injection and Maball 500Mg Injection.